{
  "claim_id": "claim_002",
  "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
  "document": {
    "pdf_name": "Liu_et_al.__2024_"
  },
  "extraction_result": {
    "success": true,
    "total_snippets_found": 4
  },
  "extracted_evidence": [
    {
      "id": "comp_1",
      "quote": "Sequence analyses All the testing viruses used in this study were sequenced. Sequences were analyzed against the sequences of candidate vaccine viruses (CVV) of the study vaccines as deposited in Global Initiative on Sharing Avian Influenza Data (GISAID) database by BioEdit version 7.0.9.0 (Table 1).",
      "relevance_explanation": "This quote shows that sequence analysis was performed to compare the viruses used in vaccines to reference strains, which is necessary to detect mutations that may arise during production, such as those that could occur in egg- or cell-based vaccine manufacturing.",
      "source": "completeness_check",
      "metadata": {
        "extraction_round": 2,
        "targeted_aspect": "general"
      }
    },
    {
      "id": "comp_2",
      "quote": "Egg grown A (H3 N2) viruses were propagated in 10 day old embryonated chicken eggs, cell grown A (H3 N2) viruses were propagated in stably transfected MDCK cells with c... A (H1 N1) pdm09 and influenza B viruses were propagated in Madin-Darby canine kidney (MDCK) cells. ... Egg- and cell (MDCK)-propagated A/Michigan/45/2015 (H1 N1) pdm09, B/Colorado/06/2017 (B/Victoria), and B/Phuket/3073/2013 (B/Yamagata) viruses were tested in year 1, Egg propagated A/Brisbane/02/2018 (H1 N1) pdm09, cell propagated A/Idaho/7/2018 (H1 N1) pdm09, egg- and cell propagated B/Colorado/06/2017 (B/Victoria) and B/Phuket/3073/2013 (B/Yamagata) viruses ...",
      "relevance_explanation": "This quote details the propagation of vaccine viruses in eggs and cell cultures, which is the process during which adaptive mutations can occur, supporting the claim that such mutations may develop during production.",
      "source": "completeness_check",
      "metadata": {
        "extraction_round": 2,
        "targeted_aspect": "general"
      }
    },
    {
      "id": "comp_3",
      "quote": "For A (H3 N2), RIV4 vaccination not only improved the quality of the functional neutralizing antibody ... However, for A (H1 N1) pdm09 and B viruses, the difference in HI antibody versus the total HA head binding antibody levels among 4 vaccine groups was less consistent suggesting that the magnitude of improvement differ",
      "relevance_explanation": "This quote suggests that differences in immune response quality between vaccine types may be due to changes in the HA protein, which can result from mutations acquired during production in eggs or cells, thus potentially affecting effectiveness.",
      "source": "completeness_check",
      "metadata": {
        "extraction_round": 2,
        "targeted_aspect": "general"
      }
    },
    {
      "id": "comp_4",
      "quote": "Comparing pre- and 1 month post vaccination, A (H3 N2) HA stalk binding antibodies were significantly boosted in ccIIV4-RIV4, RIV4-RIV4, IIV4-ccIIV4, and IIV4-RIV4 arms, while A (H1 N1) pdm09 HA stalk binding antibodies were also significantly boosted in ccIIV4-ccIIV4 and RIV4-ccIIV4 arms (Fig. 8 C). However, fold rise in both A (H1 N1) pdm09 HA stalk and A (H3 N2) HA stalk antibodies were low (GM fold rise <1.78) with no significant difference (p > 0.05) among all 7 repeat vaccination arms (Fig 8 D) tion (C, D).",
      "relevance_explanation": "This quote indicates that despite vaccination, the immune response to certain viral components was limited, which may be due to mutations in the HA protein that arise during egg or cell-based vaccine production, thus reducing effectiveness.",
      "source": "completeness_check",
      "metadata": {
        "extraction_round": 2,
        "targeted_aspect": "general"
      }
    }
  ]
}